Demographic data and concomitant medications
| Pts | Age | Diagnosis | Concomitant liver injury | Concomitant Therapy | HCV IFN-free treatment | HCV title Before | HCV title After | Duration of treatment (months) | AE/flare (n) |
|---|---|---|---|---|---|---|---|---|---|
| 01 | 62 | PA | HBV infection | INFLIXIMAB | + Ribavirina | 2110126 | <12 | 6 | 0 |
| + Declatasvir | |||||||||
| + Sofosbuvir | 2110126 | ||||||||
| 02 | 52 | PA | No | ADALIMUMAB | + Ribavirina | 2235436 | <12 | 3 | 0 |
| + Sofosbuvir | |||||||||
| 03 | 61 | EnA | HBV infection | AZATIOPRINA | + Desabuvir | 7034701 | <12 | 3 | 0 |
| + Ombitasvir | |||||||||
| + Paritaprevir | |||||||||
| + Ritonavir | |||||||||
| 04 | 46 | RA | No | ETANERCEPT | +R ibavirina | 2633651 | <12 | 3 | 0 |
| + Sofosbuvir | |||||||||
| 05 | 29 | SA | No | ETANERCEPT | + Ribavirina | 2168665 | <12 | 3 | 0 |
| + Desabuvir | |||||||||
| + Ombitasvir | |||||||||
| + Paritaprevir | |||||||||
| + Ritonavir | |||||||||